Loading…
Lobbying Spend
—
Filings
16
Firms Hired
1
Active Period
2011–2014
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Independent Innovator and Repurposing Act
2014 · second_quarter · Firm: ENDGAME STRATEGIES, LLC
Issues relating to drug innovation, drug repurposing, intellectual property protections for innovators, and the Hatch-Waxman Act. The Independent Innovator and Repurposing Act, HR 4287; S 2150
Client expense: — · Firm income: $15,000
Matched citations: HR 4287
Independent Innovator and Repurposing Act
2014 · second_quarter · Firm: ENDGAME STRATEGIES, LLC
Issues relating to drug innovation, drug repurposing, intellectual property protections for innovators, and the Hatch-Waxman Act. The Independent Innovator and Repurposing Act, HR 4287; S 2150
Client expense: — · Firm income: $15,000
Matched citations: S 2150
Independent Innovator and Repurposing Act
2014 · first_quarter · Firm: ENDGAME STRATEGIES, LLC
Issues relating to drug innovation, drug repurposing, intellectual property protections for innovators; and the Hatch-Waxman Act. The Independent Innovator and Repurposing Act, S. 2150; HR 4287
Client expense: — · Firm income: $30,000
Matched citations: HR 4287
Independent Innovator and Repurposing Act
2014 · first_quarter · Firm: ENDGAME STRATEGIES, LLC
Issues relating to drug innovation, drug repurposing, intellectual property protections for innovators; and the Hatch-Waxman Act. The Independent Innovator and Repurposing Act, S. 2150; HR 4287
Client expense: — · Firm income: $30,000
Matched citations: S. 2150
Source: Senate LDA